FDA NDC Directory · JSON-LD · Markdown

Ofev

NDC 0597-0145 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namenintedanib
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA205832
Dosage form / routeCAPSULE · ORAL
Active ingredientsNINTEDANIB ESYLATE (150 mg/1)
Marketing started20141015
Package count1

External sources

Source: openFDA. Public-domain (CC0).